Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 2nd August 2016
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

EMA launches consultation on development of TB medicines
Pills in a jar
Existing treatments for TB are not effective at combatting the disease.

Comments invited on draft guidance until 31 January 2017

A public consultation on revised guidance on the development of new medicines to treat tuberculosis (TB) has been launched by the European Medicines Agency (EMA).

The revised guidance takes into account a recent shift towards developing new regimes to treat TB, instead of focusing on single medicines.

Stakeholders can send their comments to the EMA until 31 January 2017 and, in November 2016, EMA will also host a workshop to discuss stakeholders' comments on the revised guidance. This will be broadcast live and comments will be taken into account in the finalisation of the guideline.

In 2014 there were approximately 340,000 new TB cases and 33,000 deaths, mostly from eastern and central European countries. Although the disease is slowly declining worldwide, the burden of TB is still high with around 1.5 million fatalities a year.

Existing treatments for TB are not effective at combatting the disease because they are lengthy, complex and generally show reduced efficacy against MDR-TB. They also impose a heavy burden on patients, families and healthcare systems.

The EMA say that new TB medicines and regimes that are simpler to administer, are of shorter duration, and can overcome drug resistance are 'urgently needed'.

Comments on the draft guidelines should be sent to idwpsecretariat@ema.europa.eu using this form.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.